![](/img/cover-not-exists.png)
Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
Brent A. Neuschwander-Tetri, Elizabeth M. Brunt, Kent R. Wehmeier, Craig A. Sponseller, Karen Hampton, Bruce R. BaconVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0168-8278(03)00027-8
File:
PDF, 188 KB
english, 2003